Hospital infection control strategies for vancomycin- Resistant Enterococcus, methicillin-resistant staphylococcus aureus and clostridium difficile

CMAJ. Canadian Medical Association Journal

Volumn 180, Issue 6, 2009, Pages 627-631

  Johnston, B Lynn ^a   Bryce, Elizabeth ^b  

^a Capital District Health Authority   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BLEACHING AGENT; DISINFECTANT AGENT; HYDROGEN PEROXIDE; METICILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CULTURE; CLINICAL PROTOCOL; CLOSTRIDIUM DIFFICILE; COST EFFECTIVENESS ANALYSIS; DEVICE; DISEASE SEVERITY; DISEASE TRANSMISSION; FACE MASK; GLOVE; HAND WASHING; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HIGH RISK PATIENT; HOSPITAL HYGIENE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION CONTROL; LENGTH OF STAY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PATIENT CARE; PROTECTIVE CLOTHING; REVIEW; SCREENING; STAFF TRAINING; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 62649090775     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.080195     Document Type: Review

References (79)

1. Gmndmann H. Aires-de- Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public health threat. Lancet 2006;368:874-85.
2. Bouchillon SK, Johnson BM, Hoban DJ, et al. Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Entero-coccus faecium, and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2. Int J Antimicrob Agents 2004;24:119-24.
3. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY antimicrobial surveillance program (1997-2002). Diagn Microbiol Infect Dis 2004;50:59-69.
4. Kuijper EJ, Coignard B, Brazier J, et al. Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe. Euro SurveM 2007; 12:El-2. Available: www.emxmirceillance.org/em/vl2n06/1206-221. asp (accessed 2009 Feb. 9).
5. Archibald LK, Banerjee SN, Jarvis WR. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 2004; 189:1585-9.
6. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. EMERGEncy ID Net Study Group. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666-74.
7. National Nosocomial Infections Surveillance System Report. Data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999:27:520-32.
8. Loo VG, Pokier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442-9.
9. Gilbert M, MacDonald J, Louie M, et al. Prevalence of USA300 colonization or infection and associated variables during an outbreak of community-associated rne- thicillin-resistant Staphylococcus aureus in a marginalized urban population. Can J Infect Dis Med Microbiol 2007; 18:357-62.
10. Ofner-Agostini M, Johnston BL, Simor A, et al. Vancomycin-resistant enterococci in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2005. Infect Control Hasp Epidemiol 2008;29:271-4.
11. Pépin J, Valiquette L, Alary ME. Clostridium difficile-associated diarrhea in a region of Quebec from 1991-2003. CMAJ 2004;171:466-72.
12. Canadian Nosocomial Infection Surveillance Program, Public Health Agency of Canada. Surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals - a report update from the Canadian Nosocomial Infection Surveillance Program. Can Commun Dis Rep 2005;31:33-40.
13. For whom the bug tolls: MRSA kills more people in US annually than HIV/AIDS. Hosp Infect Control 2007:133-7.
14. Canadian Nosocomial Infection Surveillance Program (CN1SP). Surveillance for methicillin-resistant Staphylococcus aureus (MRSA) in patients hospitalized in Canadian acute-care hospitals participating in CN1SP, 2006-2007: preliminary results. Ottawa (ON); The Public Health Agency of Canada. Accessed: www.phac-aspc.gc.ca/nois-sinp/pdf/mrsa-sarm-eng.pdf (accessed 2009 Feb. 17).
15. Johnston BL, Conly JM. Clostridium difficile: the evoking story. Can J Infect Dis Med Microbiol 2007;18:341-5.
16. Dubberke ER, Reshe KA, Olsen MA, et al. Evaluation of ''CDAD pressure" as a risk factor for Clostridium difficile-associated disease. Arch Intern Med 2007;167:1092-7.
17. Merrer J, Santoli F, Appere de Vecchi C, et al. "Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2000;21:718-23.
18. Bonten MJ, Slaughter S, Ambergen AW, et al. The role of colonization pressure in the spread of vancomycin-resistant enterococci. Arch Intern Med 1998; 158:1127-32.
19. McFarland LV, Mulligan ME, Kok RYY, et al. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204-10.
20. Dubberke ER, Reske KA, Noble-Wang J, et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control 2007;35:315-8.
21. Boyce JM, Potter-Bynoe G, Chenevert C, et al. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol 1997;18:622-7.
22. Oie S, Hosokawa 1, Kamiya A. Contamination of room door handles by methicillin- sensitive/methicillin-resistant Staphylococcus aureus. J Hosp Infect 2002:51:140-3.
23. Noble MA, Isaac-Renton JL, Bryce EA, et al. The toilet as a transmission vector of vancomycin-resistant enterococci. J Hosp Infect 1998;40:237-41.
24. Martinez JA, Ruthazer R, Hansjosten K, et al. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. Arch Intern Med 2003; 163:1905-12.
25. Pittet D, Dharan S, Touveneau S, et al. Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med 1999; 159:821-6.
26. Larson EL, Early E, Cloonan P, et al. An organizational climate intervention associated with increased handwashing and decreased nosocomial infections. Behav Med 2000;26:14-22.
27. Pittet D, Hugoimet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 200G;356:1307-12.
28. Gopal Rao G, Jeanes A, Osman M. Marketing hand hygiene in hospitals - a case study. J Hosp Infect 2002;50:42-7.
29. MacDonald A, Dinah F, MacKenzie D, et al. Performance feedback of hand hygiene, using alcohol gel as the skin decontaminant, reduces the number of inpatients newly affected by MRSA and antibiotic costs. J Hasp Infect 2004;56:56-63.
30. Bischoff WE, Reynolds TM, Sessler CN, et al. Handwashing compliance by health care workers. The impact of introducing an accessible, alcohol-based hand antiseptic. Arch Intern Med 2000;160:1017-21.
31. Trick WE, Vernon MO, Welbel SF, et al. Chicago Antimicrobial Resistance Project. Multicenter intervention program to increase adherence to hand hygiene recommendations and glove use and the incidence of antimicrobial resistance. Infect Control Hosp Epidemiol 2007;28:42-9.
32. Wisniewski MF, Kim S, Trick WE, et al.; Chicago Antimicrobial Resistance Project. Effect of education on hand hygiene beliefs and practices: a 5-year program. Infect Control Hosp Epidemiol 2007:28:88-91.
33. Larson E, Kretzer EK. Compliance with handwashing and barrier precautions. J Hosp Infect 1995;30fSuppl):88-106.
34. Rosenthal VD, Guzman S, Safdar N. Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control 2005;33:392-7.
35. Pittet D,Simon A, Hugonnet S, et al. Hand hygiene among physicians: performance, beliefs, and perceptions. Ann Intern Med 2004:141:1-8.
36. Andreasen AR. Marketing social change: changing behavior to promote health, social development, and the environment. San Francisco (CA): Jossey-Bass; 1995.
37. Sax H, Allegranzi B, Uckay I, et al. "My five moments for hand hygiene": a user- centred design approach to understand, train, monitor and report hand hygiene. J Hosp Infect 2007:67:9-21.
38. Mali MW, Deshpande S, Rothschild ML. Social marketing: a behavior change technology for infection control. Am J Infect Control 2006;34:452-7.
39. Pinfold JV. Analysis of different communication channels for promoting hygiene behaviour. Health Educ Res 1999;14:629-39.
40. Daschner F, Schuster A. Disinfection and the prevention of infectious disease: no adverse effects? Am J Infect Control 2004;32:224-5.
41. Rutala WA, Weber DJ. The benefits of surface disinfection. Am J Infect Control 2004;32:226-32.
42. Pratt RJ, Pellowe CM, Wilson JA, et al. epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007;65:81-64.
43. Rampling A, Wiseman S, Davis L, et al. Evidence that hospital hygiene is important in the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2001;49: 109-16.
44. Fawley WN, Underwood S, Freeman J, et al. Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains. Infect Control Hosp Epidemiol 2007;28:920-5.
45. Perez J, Springthorpe VS, Sattar SA. Activity of selected oxidizing microhicides against the spores of Clostridium difficile: relevance to environmental control. Am J Infect Control 2005;33:320-5.
46. Wilcox. MH, Fawley WN, Wigglesworth N, et al. Comparison of the effect of detergent versus hypochlorite on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect 2003;54:109-14.
47. Routine practices and additional precautions for preventing the transmission of infection in health care. Can Comm Dis Rep 1999; 25S4.
48. Siegal JD, Rhinehart E, Jackson M, et al.; the Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant strains organisms in healthcare settings, 2006. Atlanta (GA): Center for Disease Control and Prevention; 2006. Available: www.cdc.gov/ncidod/dhqp/ (accessed 2009 Feb. 9).
49. Muto CA, Jemigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362-86.
50. Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA 2003;290:1899-905.
51. Tarzi S, Kennedy P, Stone S, et al. Methicillin-resistant Staphylococcus aureus: psychological impact of hospitalization and isolation in an older adult population. J Hosp Infect 2001:49:250-4.
52. Gastmeier P, Schwab F, Geffers C, et al. To isolate or not to isolate? Analysis of data from the German nosocomial infection surveillance system regarding the placement of patients with methicillin-resistant Staphylococcus aureus in private rooms in intensive care units. Infect Control Hosp Epidemiol 2004;25:109-13.
53. Yoonchang SW, Peck KR, Kim OS, et al. Efficacy of infection control strategies to reduce transmission of vancomvein-resistant enterococci in a tertiary care hospital in Korea: a 4-year follow-up study. Infect Control Hosp Epidemiol 2007;28: 493-5. Epub 2007 Feb. 26.
54. West TE, Guerry C, Hiott M, et al. Effect of targeted surveillance for control of methicillin-resistant Staphylococcus aureus in a community hospital system. Infect Control Hosp Epidemiol 2006;27:233-8.
55. Mangini E, Segal-Maurer S, Burns J, et al. Impact of contact and droplet precautions on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus infection. Infect Control Hosp Epidemiol 2007;28:1261-6.
56. Schelenz S, Tucker D, Georgeu C, et al. Significant reduction of endemic MRSA acquisition and infection in cardithoracic patients by means of an enhanced targeted infection control programme. J Hosp Infect 2005;60:104-10.
57. Hartstein Al, Denny MA, Morthland Y, et al. Control of methicillin-resistant Staphylococcus aureus in a hospital and an intensive care unit. Infect Control Hosp Epidemiol 1995;16:405-11.
58. Jernigan JA, Titus MG, Droschel DH, et al. Effectiveness of contact isolation during a hospital outbreak: of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996;143:496-504.
59. Montecalvo MA, Jarvis WR, Uman J, et al. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern Med 1999;131:269-72.
60. Slaughter S, Hayden MK, Nathan C, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin- resistant enterococci in a medical intensive care unit. Ann Intern Med 1996;125:448-56.
61. Karenmer TB, Durbin LJ, Simonton BM, et al. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2002;51:126-32.
62. Cooper BS, Stone SP, Kibbler CC, et al. Isolation measures in the hospital management of methicillin-resistant Staphylococcus aureus (MRSA): systematic review of the literature. 2004;329:533-8.
63. Cepeda JA, Whitehouse T, Cooper B, et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive care units: prospective two-centre study. Lancet 2005;365:295-304.
64. Verhoef J, Beaujean D, Blok H, et al. A Dutch approach to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1999;18:461-6.
65. Wertheim HFL, Vos MC, Boelens HAM, et al. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect 2004;56:321-5.
66. van Trijp MJCA, Melles DC, Hendriks WDH, et al. Successful control of widespread methicillin-resistant Staphylococcus aureus colonization and infection in a large teaching hospital in the Netherlands. Infect Control Hosp Epidemiol 2007;28:970-5.
67. Dailey L, Coombs GW, O'Brien EG, et al. Methicillin-resistant Staphylococcus aureus, Western Australia. Emerg Infect Dis 2005;11:1584-90.
68. Boyce JM, Opal SM, Potter-Bynoe G, et al. Spread of metlhcillin-resistant Staphylococcus aureus in a hospital after exposure to a health care worked with chronic sinusitis. Clin Infect Dis 1993;17:496-504.
69. Ofner-Agostini M, Varali M, Johnston BL, et al. Infection control and antimicrobial restrictionpractices for antimicrobial-resistant organisms in Canadian tertiary care hospitals. Am J Infect Control 2007;35:563-8.
70. Johnson S, Gerding DN, Olson MM, et al. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 1990; 88:137-40.
71. Papia G, Louie M, Tralla A, et al. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: Is it cost-effective? Infect Control Hosp Epidemiol 1999;20:473-7.
72. Clancy M, Graepler A, Wilson M, et al. Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in hospital. Infect Control Hosp Epidemiol 2006;27:1009-17.
73. Shitrit P, Gottesman B-T, Katzir M, et al. Active surveillance for methicillin-resistant Staphylococcus aureus (MRSA) decreases the incidence of MRSA bacteremia. Infect Control Hosp Epidemiol 2006;27:1004-8.
74. West TE, Guerry C, Hiott M, et al. Effect of targeted surveillance for control of methicillin-resistant Staphylococcus aureus in a community hospital system. Infect Control Hosp Epidemiol 2006;27:233-8.
75. Muto CA, Giannetta ET, Durbin LJ, et al. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002;23:429-35.
76. Price CS, Paule S, Noskin GA, et al. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia. Clin Infect Dis 2003;37:921-8.
77. Salgado CD, Fan- BM. What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiological cultures? Infect Control Hosp Epidemiol 2006;27:116-21.
78. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982;97:309-17.
79. Weber SG, Huang SS, Oriola S, et al. Legislative mandates for use of active surveillance cultures for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and AP1C Task Force. Infect Control Hosp Epidemiol 2007;28:249-60.